Found Weight Loss Side Effects: What GLP-1 Patients Report in 2026
Complete guide to Found weight loss side effects in 2026. What GLP-1 patients experience on semaglutide and tirzepatide through Found, management strategies, and how Trimi compares at $99/mo.
Written by Trimi Medical Team. Medically reviewed by Dr. Amanda Foster, MD. Our team reviews GLP-1 side effect data and competitor platforms so patients can make informed treatment decisions with current clinical context.
Quick links: Semaglutide treatment, tirzepatide treatment, Found semaglutide review, and cancel Found and switch.
More on GLP-1 Side Effects
Understanding Found Weight Loss Side Effects
Found weight loss side effects are among the most common concerns patients research before starting GLP-1 treatment through the Found telehealth platform. Found charges $129 to $199 per month for semaglutide programs that combine compounded medication with health coaching and behavioral support. Before enrolling, patients want to know exactly what side effects to expect and how Found handles them compared to other providers.
Key Distinction
The side effects patients experience on Found are caused by the GLP-1 medication — semaglutide or tirzepatide — not by Found's platform itself. These medications work by activating GLP-1 receptors in the brain and gut, which suppresses appetite and slows gastric emptying. The gastrointestinal side effects are a direct pharmacological consequence of this mechanism, and they occur identically whether the medication is prescribed through Found, Trimi, or any other provider.
This is an essential point that many patients overlook when reading Found weight loss reviews: the side effect profile is determined by the drug, not the platform. Compounded semaglutide prescribed at Found for $129 to $199 per month has the same pharmacological effects as compounded semaglutide prescribed through Trimi at $99 per month. What does differ between providers is how they support patients through those side effects — the responsiveness of clinical teams, the depth of GLP-1 expertise, and the quality of dose titration guidance.
The clinical trial data on GLP-1 side effects comes primarily from two landmark studies. The STEP 1 trial (Wilding et al., New England Journal of Medicine, 2021) studied semaglutide 2.4mg in 1,961 adults and found an average weight loss of 14.9% over 68 weeks, with gastrointestinal events being the most commonly reported adverse effects. The SURMOUNT-1 trial (Jastreboff et al., New England Journal of Medicine, 2022) studied tirzepatide in 2,539 adults and demonstrated weight loss of up to 22.5% at the highest dose, with a similar gastrointestinal side effect profile. These studies provide the foundation for understanding what Found patients — and all GLP-1 patients — should expect.
Common Side Effects Found Patients Report
The side effects below are reported across all GLP-1 medications including those prescribed through Found. Incidence rates come from published clinical trial data for semaglutide (STEP trials) and tirzepatide (SURMOUNT trials). Real-world rates may vary based on individual factors including dose, titration speed, diet, and concurrent medications.
| Side Effect | Semaglutide Incidence | Tirzepatide Incidence | Typical Duration |
|---|---|---|---|
| Nausea | 40-44% | 24-33% | 2-6 weeks per dose increase |
| Diarrhea | 29-31% | 17-23% | 1-3 weeks |
| Vomiting | 24-27% | 9-13% | 1-2 weeks per dose increase |
| Constipation | 23-25% | 17-22% | Variable; may persist |
| Abdominal pain | 20-22% | 12-16% | 1-4 weeks |
| Headache | 13-14% | 8-10% | First 1-2 weeks |
| Fatigue | 11-12% | 7-9% | First 2-4 weeks |
| Dyspepsia | 8-10% | 8-11% | Variable |
| Injection site reactions | 3-5% | 3-7% | 24-48 hours |
| Acid reflux / GERD | 5-8% | 5-9% | Variable; may persist |
Clinical Trial Context
Semaglutide rates are from the STEP 1 trial (Wilding et al., NEJM, 2021) and STEP trials program. Tirzepatide rates are from the SURMOUNT-1 trial (Jastreboff et al., NEJM, 2022). These rates apply to all patients on these medications regardless of provider. Found patients, Trimi patients, and patients prescribed by primary care physicians all experience the same incidence rates.
Most patients notice that gastrointestinal side effects are most pronounced during the dose escalation phase — the first several weeks at each new dose level. As the body adapts to the medication, nausea and other GI symptoms typically decrease. In the STEP 1 trial, the majority of GI events were mild to moderate in severity, and only about 7% of participants discontinued treatment due to adverse events. This means more than 90% of patients were able to continue treatment with manageable side effects. For additional context, see our detailed semaglutide side effects guide and tirzepatide side effects guide.
Found vs Trimi: Side Effect Support and Pricing
Since Found and Trimi prescribe the same GLP-1 medications, the side effects are identical. The meaningful differences lie in pricing, provider specialization, and how each platform supports patients through side effect management. Here is a direct comparison of what matters when side effects occur.
| Feature | Found | Trimi |
|---|---|---|
| Monthly Price (Semaglutide) | $129 - $199/mo | $99/mo |
| Monthly Price (Tirzepatide) | $199+/mo | $125/mo |
| Side Effect Support | Coaching + provider messaging | Specialized GLP-1 provider team |
| Dose Adjustment Responsiveness | Variable; depends on provider load | Focused — GLP-1 is the core practice |
| Provider Specialization | General weight loss + coaching | Dedicated weight management / GLP-1 |
| Anti-Nausea Guidance | Through coaching program | Included with provider support |
| Consultation Fee | Included in monthly price | Free — always included |
| Contract Required | Some plans; varies | No — month-to-month always |
| Medication Options | Semaglutide, tirzepatide, others | Semaglutide, tirzepatide, retatrutide |
| 12-Month Total (Semaglutide) | $1,548 - $2,388 | $1,188 |
| Annual Savings with Trimi | — | $360 - $1,200 |
The core difference is that Found bundles coaching infrastructure into their monthly fee, which raises the price without changing the medication or its side effects. Patients who primarily need responsive clinical support for dose adjustments, side effect guidance, and medication management may find better value with a provider like Trimi that dedicates its resources to GLP-1 expertise rather than spreading them across a coaching platform. For a broader comparison, see our Found vs Trimi cost comparison.
Managing Found Weight Loss Side Effects
Whether you are currently on Found, considering Found, or using another GLP-1 provider, these evidence-based strategies can significantly reduce the severity and duration of common side effects. These recommendations are consistent with clinical guidelines and applicable regardless of prescribing platform.
Follow a gradual dose titration schedule
Rushing through dose increases is the single biggest contributor to severe side effects. Ask your provider to slow the escalation if side effects are difficult to manage. Staying at a lower dose for an extra 2 to 4 weeks before increasing can dramatically improve tolerability without significantly delaying weight loss results.
Eat smaller, more frequent meals throughout the day
GLP-1 medications slow gastric emptying, meaning food stays in the stomach longer. Large meals overwhelm the system and worsen nausea. Eating 4 to 6 smaller meals instead of 2 to 3 large ones reduces the volume your slowed stomach needs to process at once.
Prioritize bland, low-fat foods during dose escalation
High-fat, greasy, and heavily spiced foods are the most reliable dietary triggers for GLP-1 nausea. During the first 2 to 3 weeks at each new dose level, lean proteins, whole grains, steamed vegetables, and simple carbohydrates are better tolerated. You can gradually reintroduce more variety as your body adjusts.
Maintain hydration — aim for 64 ounces of water daily minimum
Vomiting and diarrhea cause fluid loss, and GLP-1 medications can reduce your natural thirst sensation. Dehydration worsens nearly every side effect including nausea, headache, fatigue, and constipation. Set hydration reminders and consider electrolyte supplementation if you are experiencing significant GI symptoms.
Time your injection strategically
Many patients find that injecting in the evening or before bed reduces the impact of initial nausea, as they sleep through the first hours when side effects tend to peak. Others prefer injecting before a rest day. Experiment to find what timing works best for your schedule and tolerance.
Use ginger and other natural anti-nausea strategies
Ginger tea, ginger chews, and small sips of ginger ale can help with mild nausea. Peppermint tea and bland crackers are also effective for some patients. These strategies do not replace medical management for severe symptoms but can help with day-to-day comfort during dose escalation.
Communicate proactively with your provider
Do not wait until side effects are unbearable to reach out. A responsive provider experienced in GLP-1 prescribing can adjust your dose, recommend supportive medications, or modify your titration schedule before side effects force you to consider discontinuation. The quality of this communication is where provider choice matters most.
For detailed dietary guidance during GLP-1 treatment, see our guides on best foods for semaglutide and managing GLP-1 side effects.
When to Contact Your Provider: Serious Warning Signs
While the vast majority of GLP-1 side effects are gastrointestinal and manageable, rare but serious adverse events can occur. These apply equally to Found patients and patients on any GLP-1 medication from any provider. Knowing these warning signs is a critical part of safe treatment.
Pancreatitis
Severe, persistent abdominal pain that may radiate to the back, accompanied by nausea and vomiting. This pain is distinctly different from the mild GI discomfort that is a common side effect — it is intense, constant, and does not resolve with rest or dietary changes. Stop the medication and seek emergency care immediately.
Thyroid concerns (boxed warning)
A new lump or swelling in the neck, difficulty swallowing, hoarseness that does not resolve, or persistent shortness of breath. GLP-1 medications carry an FDA boxed warning about thyroid C-cell tumors based on animal studies. The risk in humans is not fully established, but patients with a personal or family history of medullary thyroid carcinoma or MEN2 syndrome should not use these medications.
Gallbladder disease
Sudden or worsening pain in the upper right abdomen, especially after meals, fever, jaundice (yellowing of the skin or eyes), and clay-colored stools. Rapid weight loss from any cause increases gallbladder disease risk, and GLP-1 medications may contribute independently. The STEP trials reported higher rates of gallbladder-related events in the treatment group.
Severe allergic reaction
Difficulty breathing, swelling of the face, lips, tongue, or throat, rapid heartbeat, severe rash, or dizziness after injection. While rare, anaphylaxis to injectable medications is possible and constitutes a medical emergency requiring immediate 911 response.
Kidney problems
Decreased urination, unusual swelling in the legs or feet, persistent fatigue, or dark-colored urine. Severe dehydration from persistent vomiting or diarrhea can impair kidney function, particularly in patients with pre-existing kidney disease. Maintaining hydration is essential for prevention.
Severe hypoglycemia (in patients on insulin or sulfonylureas)
Shakiness, confusion, rapid heartbeat, sweating, blurred vision, or loss of consciousness. While GLP-1 medications alone rarely cause hypoglycemia, combining them with insulin or sulfonylureas significantly increases this risk. Your provider should adjust concurrent diabetes medications when starting GLP-1 treatment.
Emergency Action
For severe or life-threatening symptoms, do not wait to message Found or any telehealth provider through an app. Call 911 or go directly to the nearest emergency department. Telehealth messaging is appropriate for non-urgent side effect questions and dose adjustments — not for emergencies. For complete safety information, see our important safety information page.
Does Found's Coaching Reduce Side Effects?
Found's value proposition includes health coaching bundled with medication, raising the question of whether this coaching reduces the side effects patients experience. The honest answer is nuanced: coaching cannot change the medication's pharmacology, but it can help patients implement strategies that improve tolerability.
Found's coaching may help patients make dietary modifications, adopt better hydration habits, and manage expectations during dose escalation. These are legitimate and useful interventions. However, the same strategies are well-documented in clinical guidelines and available from any competent GLP-1 provider. The question is whether Found's coaching infrastructure adds enough value beyond standard clinical guidance to justify paying $30 to $100 more per month than a medication-focused provider.
For patients who thrive with structured programs and external accountability, Found's coaching may improve adherence and indirectly reduce side effects by encouraging consistent dietary habits. For patients who are self-directed or who have access to other support systems (nutritionist, trainer, supportive partner), the coaching premium may not provide proportional value. Trimi provides specialized GLP-1 provider guidance at $99 per month for semaglutide — including the same dose titration management and side effect support that drives real clinical outcomes.
Semaglutide vs Tirzepatide Side Effects on Found
Found prescribes both semaglutide and tirzepatide, and the side effect profiles differ between these two medications. Understanding these differences can inform your treatment choice with your provider.
Nausea rates are generally lower with tirzepatide (24-33%) compared to semaglutide (40-44%) at equivalent therapeutic doses
Vomiting is significantly less common with tirzepatide (9-13%) compared to semaglutide (24-27%)
Constipation rates are similar between the two medications (17-25% range for both)
Injection site reactions may be slightly more common with tirzepatide due to the dual-receptor mechanism
Tirzepatide demonstrated greater weight loss (up to 22.5% in SURMOUNT-1) compared to semaglutide (14.9% in STEP 1), potentially offering a better efficacy-to-side-effect ratio
Both medications carry the same boxed warning regarding thyroid C-cell tumors from animal studies
Patients who experience intolerable nausea or vomiting on semaglutide may tolerate tirzepatide better. If you are on Found's semaglutide program and struggling with side effects, discussing a medication switch with your provider is a reasonable clinical option. Trimi offers tirzepatide at $125 per month — considerably less than Found's tirzepatide pricing. For a detailed medication comparison, see our semaglutide vs tirzepatide guide.
Found Side Effects Timeline: What to Expect Month by Month
Understanding the typical timeline of GLP-1 side effects helps set realistic expectations and reduces anxiety during treatment. This timeline applies to Found patients and all GLP-1 patients regardless of provider.
Weeks 1-4 (Starting Dose)
Most patients experience their first wave of side effects as the medication begins working. Nausea is the most common initial complaint, typically mild to moderate. Some patients notice reduced appetite almost immediately. GI symptoms are usually manageable with dietary adjustments. This is the adjustment period where your body is adapting to the medication's effects on gastric motility and appetite signaling.
Weeks 4-8 (First Dose Increase)
Each dose escalation triggers a new round of side effects, though usually milder than the initial onset. The body has partially adapted by this point. Nausea may return briefly but typically resolves faster than during the first weeks. Weight loss accelerates as the dose increases. Constipation may become more noticeable as the higher dose further slows gastric transit.
Months 2-4 (Active Titration)
Most patients are actively titrating to their therapeutic dose during this period. Side effects follow a cyclical pattern — worsening briefly after each increase, then improving. By month 3, many patients report that side effects are significantly less disruptive than they were initially. Patients who communicate well with their provider about tolerance can optimize this phase.
Months 4-6 (Maintenance Phase)
Most patients have reached their target dose and the body has substantially adjusted. Nausea is typically minimal or absent. Constipation may persist and require ongoing management. Appetite suppression is well-established. This is when the medication's benefits are most clearly realized with the fewest side effects.
Months 6-12 and Beyond
Long-term side effects are generally limited. Some patients report persistent changes in food preferences, occasional GI sensitivity to certain foods, and ongoing constipation. Serious side effects, if they occur, can emerge at any point in treatment and require ongoing vigilance regardless of how long you have been on the medication.
For a complete timeline of what to expect, see our semaglutide results timeline.
The Bottom Line on Found Weight Loss Side Effects
Found weight loss side effects are GLP-1 medication side effects — they come from semaglutide and tirzepatide, not from Found's platform. Every patient on these medications, regardless of provider, faces the same pharmacological side effect profile: nausea, diarrhea, constipation, vomiting, and other GI symptoms that are most pronounced during dose escalation and typically improve over time. Clinical trial data shows that the vast majority of patients tolerate these medications successfully with appropriate management.
Found's coaching model adds a layer of behavioral support that some patients find helpful for navigating side effects and building sustainable habits. That coaching is bundled into their $129 to $199 monthly price for semaglutide. For patients who primarily need expert clinical management of their GLP-1 treatment — responsive dose titration, specialized side effect guidance, and affordable medication access — Trimi offers the same compounded semaglutide at $99 per month and tirzepatide at $125 per month, with dedicated weight management providers who manage GLP-1 side effects as their core clinical focus.
The $360 to $1,200 saved annually by choosing Trimi over Found does not come at the cost of side effect management quality. It comes from not paying for a coaching infrastructure that many patients do not fully utilize. If you are currently on Found and experiencing side effects, the management strategies in this article apply directly to your situation. If you are considering a switch for better value, see our guide on how to cancel Found and switch providers.
Frequently Asked Questions
What are the most common Found weight loss side effects?
The most common side effects patients report on Found weight loss medications are nausea (40-44%), diarrhea (29-31%), vomiting (24-27%), constipation (23-25%), abdominal pain (20-22%), headache (13-14%), and fatigue (11-12%). These side effects come from the GLP-1 medication itself — semaglutide or tirzepatide — not from Found's platform. The same side effects occur regardless of which provider prescribes the medication.
Are Found weight loss side effects different from other providers?
No. Found prescribes compounded semaglutide and tirzepatide, which are the same active ingredients prescribed by Trimi, Calibrate, Ro, and other telehealth providers. The side effect profile is determined by the medication's pharmacology, not by the prescribing platform. What differs between providers is the quality of side effect support, responsiveness to dose adjustment requests, and specialization in GLP-1 management.
How does Found help manage GLP-1 side effects?
Found provides provider access through their platform messaging system and includes coaching support as part of their $129 to $199 monthly fee. Patients can report side effects and receive dietary guidance, dose adjustment recommendations, and general management strategies through the app. However, because Found bundles coaching into the price, patients pay for this support infrastructure whether they use it extensively or not.
Do Found's side effects go away over time?
Most GLP-1 side effects improve significantly within 4 to 8 weeks at each dose level. Nausea, vomiting, and diarrhea are most intense during dose escalation periods and tend to decrease as the body adjusts. Some patients experience minimal side effects after the first few months of treatment. Constipation may persist longer for some patients due to the medication's effect on gastric motility.
Can I reduce Found weight loss side effects by adjusting my dose?
Yes. Dose titration is the primary clinical tool for managing GLP-1 side effects. Slowing the escalation schedule — staying at a lower dose for additional weeks before increasing — can significantly reduce nausea and GI symptoms. Found's providers can adjust your titration schedule, though response times for dose adjustment requests vary. Trimi's specialized GLP-1 providers offer focused dose optimization as part of their $99 per month program.
Is Trimi better than Found for managing side effects?
Trimi's providers specialize exclusively in weight management and GLP-1 prescribing, which means they manage side effect questions daily with deep, focused expertise. At $99 per month for semaglutide compared to Found's $129 to $199, patients save $30 to $100 monthly while receiving dedicated GLP-1 support. Both platforms provide access to licensed providers, but Trimi's specialization can mean more nuanced side effect management.
When should I be concerned about side effects on Found medications?
Seek immediate medical attention for severe persistent abdominal pain (possible pancreatitis), signs of allergic reaction (difficulty breathing, facial swelling), symptoms of thyroid tumors (neck lump, difficulty swallowing, hoarseness), persistent vomiting preventing hydration, or signs of gallbladder problems (upper right abdominal pain, jaundice). Do not wait to message Found through the app for severe symptoms — call 911 or visit an emergency room.
Sources & References
- Wilding JPH, et al. "Once-weekly semaglutide in adults with overweight or obesity." New England Journal of Medicine, 2021;384:989-1002. (STEP 1 trial)
- Jastreboff AM, et al. "Tirzepatide once weekly for the treatment of obesity." New England Journal of Medicine, 2022;387:205-216. (SURMOUNT-1 trial)
- Wegovy (semaglutide) prescribing information. U.S. Food and Drug Administration.
- Zepbound (tirzepatide) prescribing information. U.S. Food and Drug Administration.
- Found weight loss program and pricing information.
- National Institute of Diabetes and Digestive and Kidney Diseases. Prescription medications to treat overweight and obesity.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. If you experience severe side effects, contact your healthcare provider immediately or call 911. Side effect management should always be guided by a licensed medical professional familiar with your health history. Trimi is a competitor to Found — this article aims to present balanced, medically accurate information, but readers should be aware of our perspective. Always consult a qualified healthcare provider before starting, stopping, or changing any medication.